天齊鋰業(002466.SZ):廈鎢新能源於科創板IPO獲中證監同意註冊
格隆匯6月30日丨天齊鋰業(002466.SZ)公佈,2021年6月30日,公司收到廈鎢新能源的通知,其已收到中國證監會《關於同意廈門廈鎢新能源材料股份有限公司首次公開發行股票註冊的批覆》(證監許可【2021】2262號)文件,中國證監會已於2021年6月29日同意廈鎢新能源在科創板首次公開發行股票的註冊申請。廈鎢新能源將會根據中國證監會及上交所的相關規定及要求開展後續工作。
截至公吿披露日,公司持有廈鎢新能源566.04萬股,佔其首次公開發行前總股本的3%,限售期為上市之日起12個月。公司將根據該事項進展情況及時履行信息披露義務。請廣大投資者注意投資風險。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.